Press Releases Choose Year All Items 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Search Press Releases Found 265 Results March 11, 2021 Relmada Therapeutics Announces Participation in the Oppenheimer 31st Annual Healthcare Conference February 23, 2021 Relmada Therapeutics Announces Participation in the 2021 SVB Leerink Global Healthcare Conference December 7, 2020 Relmada Therapeutics Announces Initiation of Phase 3 Program for REL-1017 as Adjunctive Treatment for Patients with Major Depressive Disorder November 17, 2020 Relmada Therapeutics to Participate in Upcoming Investor Conferences October 27, 2020 Relmada Therapeutics Expands R&D Team, Appoints Paolo Manfredi, M.D., as Acting Chief Scientific Officer, Marco Pappagallo, M.D., as Acting Chief Medical Officer and Updates R&D Milestones July 13, 2020 Relmada Therapeutics Announces Uplisting to the Nasdaq Global Select Market® June 23, 2020 Relmada Therapeutics Announces Notice of Allowance for Patent in Canada Covering REL-1017 for Treatment of Psychiatric Symptoms June 9, 2020 Relmada Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference May 29, 2020 Relmada Therapeutics to Present at the Jefferies 2020 Virtual Healthcare Conference May 27, 2020 Relmada Therapeutics Announces Outcome of End-of-Phase 2 Meeting with FDA for REL-1017 for Adjunctive Treatment of Patients with Major Depressive Disorder «...111213141516...»
